Labeling probiotics as useless is irresponsible, says IPA exec
date:Sep 12, 2018
ecific trials on disease states [such as metabolic diseases], not as prevention, but as treatment. Only time will tell whether are not these trials will be successful, but there is huge investment in that area, he concludes.